Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/130988
Title: Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicentre LAGO-AF study
Author: Bisbal, Felipe
Alarcón, Francisco
Ferrero, Ángel
González Ferrer, Juan José
Alonso, Concepción
Pachón, Marta
Tizón, Helena
Cabanas Grandío, Pilar
Sánchez, Manuel
Benito, Eva
Teis, Albert
Ruiz Granell, Ricardo
Pérez Villacastín, Julián
Viñolas, Xavier
Arias, Miguel Ángel
Vallés, Ermengol
García Campo, Enrique
Fernández Lozano, Ignacio
Villuendas, Roger
Mont Girbau, Lluís
Keywords: Fibril·lació auricular
Arrítmia
Cirurgia cardíaca
Assaigs clínics
Atrial fibrillation
Arrhythmia
Heart surgery
Clinical trials
Issue Date: 1-Sep-2018
Publisher: Oxford University Press
Abstract: Aims: Left atrial (LA) remodelling is a key determinant of atrial fibrillation (AF) ablation outcome. Optimal methods to assess this process are scarce. LA sphericity is a shape-based parameter shown to be independently associated to procedural success. In a multicentre study, we aimed to test the feasibility of assessing LA sphericity and evaluate its capability to predict procedural outcomes. Methods and results: This study included consecutive patients undergoing first AF ablation during 2013. A 3D model of the LA chamber, excluding pulmonary veins and LA appendage, was used to quantify LA volume (LAV) and LA sphericity (≥82.1% was considered spherical LA). In total, 243 patients were included across 9 centres (71% men, aged 56 ± 10 years, 44% with hypertension and 76% CHA2DS2-VASc ≤ 1). Most patients had paroxysmal AF (66%) and underwent radiofrequency ablation (60%). Mean LA diameter (LAD), LAV, and LA sphericity were 42 ± 6 mm, 100 ± 33 mL, and 82.6 ± 3.5%, respectively. Adjusted Cox models identified paroxysmal AF [hazard ratio (HR 0.54, P = 0.032)] and LA sphericity (HR 1.87, P = 0.035) as independent predictors for AF recurrence. A combined clinical-imaging score [Left Atrial Geometry and Outcome (LAGO)] including five items (AF phenotype, structural heart disease, CHA2DS2-VASc ≤ 1, LAD, and LA sphericity) classified patients at low (≤2 points) and high risk (≥3 points) of procedural failure (35% vs. 82% recurrence at 3-year follow-up, respectively; HR 3.10, P < 0.001). Conclusion: In this multicentre, real-life cohort, LA sphericity and AF phenotype were the strongest predictors of AF ablation outcome after adjustment for covariates. The LAGO score was easy to implement, identified high risk of procedural failure, and could help select optimal candidates. Clinical Trial Registration Information: NCT02373982 (http://clinicaltrials.gov/ct2/show/NCT02373982).
Note: Versió postprint del document publicat a: https://doi.org/10.1093/ehjci/jey060
It is part of: European Heart Journal-Cardiovascular Imaging, 2018, vol. 19, num. 9, p. 1002-1009
URI: http://hdl.handle.net/2445/130988
Related resource: https://doi.org/10.1093/ehjci/jey060
ISSN: 2047-2404
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
685951.pdf514.33 kBAdobe PDFView/Open    Request a copy


Embargat   Document embargat fins el 31-12-2019


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.